NCT06018012View on ClinicalTrials.gov

MRA and ABR as Early Predictors of Bilirubin-Induced Neurologic Dysfunction in Full-term Jaundiced Neonates

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

March 1, 2019

Primary Completion Date

March 1, 2021

Study Completion Date

April 1, 2021

Conditions

Neonatal Hyperbilirubinemia

Interventions

DEVICE

MRS and ABR

Magnetic Resonance Spectroscopy and Auditory Brain- stem Response Audiometry

Trial Locations (1)

31527

faculty of medicine,Tanta University, Tanta

All Listed Sponsors

lead

Tanta University

OTHER

NCT06018012 - MRA and ABR as Early Predictors of Bilirubin-Induced Neurologic Dysfunction in Full-term Jaundiced Neonates | Biotech Hunter | Biotech Hunter